These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24125437)

  • 1. TIMEBOMB revisited 10 years later: can we sustain progress or are we losing the war?
    Reichman LB
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1377-82. PubMed ID: 24125437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in tuberculosis and options available.
    Chugh S
    J Indian Med Assoc; 2010 Feb; 108(2):106-8. PubMed ID: 20839567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited access to drugs for resistant tuberculosis: a call to action.
    Bélard S; Janssen S; Osbak KK; Adegnika AA; Ondounda M; Grobusch MP
    J Public Health (Oxf); 2015 Dec; 37(4):691-3. PubMed ID: 25527468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
    Caminero JA
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):382-90. PubMed ID: 20202293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of multidrug resistant tuberculosis.
    Daley CL; Caminero JA
    Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
    Chan ED; Iseman MD
    Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to put boots on the ground: making universal access to MDR-TB treatment a reality.
    Keshavjee S; Farmer PE
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1222-5. PubMed ID: 20843411
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].
    Baylan O
    Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of drug-resistant TB with individualised DST--the way forward?
    Singhal T; Gupta N
    J Assoc Physicians India; 2014 Jul; 62(7):561-3. PubMed ID: 25672025
    [No Abstract]   [Full Text] [Related]  

  • 15. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives.
    Migliori GB; Centis R; Lange C; Richardson MD; Sotgiu G
    Curr Opin Pulm Med; 2010 May; 16(3):171-9. PubMed ID: 20134324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
    Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R
    J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-resistant and extensively drug-resistant tuberculosis in southern Africa.
    Grobusch MP
    Curr Opin Pulm Med; 2010 May; 16(3):180-5. PubMed ID: 20154624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance in new tuberculosis patients: burden and implications.
    Royce S; Falzon D; van Weezenbeek C; Dara M; Hyder K; Hopewell P; Richardson MD; Zignol M
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):511-3. PubMed ID: 23485384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.